World of DTC Marketing

AUGUST 7, 2022

Researchers found that physicians don’t think very highly of health insurance companies and believe they’re putting patients at risk with policies such as prior authorizations ahead of filling prescriptions. Health insurance policies are stressing many physicians out. What about the new bill to help Medicare patients?

Insurance 263

Insurance Doctors Government Physicians 263

PM360

APRIL 7, 2023

No one has ever described the pharma market access landscape as simple or easy to understand, and the passage of the Inflation Reduction Act (IRA) is not likely to change that. Pharma manufacturers of brands that are selected for negotiation will absolutely want to ‘pull through’ their coveted, newfound formulary position with HCPs.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

Pharmaceutical Technology

FEBRUARY 3, 2023

This market dynamic will likely intensify both if more adalimumab biosimilars receive interchangeability designation and with increased pressure in the US Pharma market due to the Inflation Reduction Act of 2022. Currently, Boehringer Ingelheim’s Cyltezon is the only adalimumab biosimilar that has received interchangeability designation.

Marketing 52

Marketing Sales Patients Management 52

Clarivate

OCTOBER 17, 2024

The Inflation Reduction Act instead allows the Centers for Medicare & Medicaid Services to begin negotiating Fair Maximum Prices for a growing list of Part D (outpatient) and Part B (physician-administered) drugs that represent the greatest cost to the federal government.

Healthcare 52

Healthcare Healthcare Government Insurance 52